Zürcher Nachrichten - US greenlights pig kidney transplant trials

EUR -
AED 3.976304
AFN 76.778832
ALL 99.310506
AMD 423.044753
ANG 1.938043
AOA 988.936945
ARS 1161.759293
AUD 1.729486
AWG 1.948643
AZN 1.845171
BAM 1.956007
BBD 2.184641
BDT 131.495125
BGN 1.959837
BHD 0.408079
BIF 3215.669885
BMD 1.08258
BND 1.452567
BOB 7.503794
BRL 6.187912
BSD 1.081914
BTN 92.479783
BWP 14.84257
BYN 3.540875
BYR 21218.558679
BZD 2.17333
CAD 1.556408
CDF 3107.003113
CHF 0.954841
CLF 0.026552
CLP 1018.902495
CNY 7.857033
CNH 7.878375
COP 4530.05402
CRC 541.462282
CUC 1.08258
CUP 28.688357
CVE 110.275647
CZK 24.961471
DJF 192.29123
DKK 7.461344
DOP 68.15784
DZD 145.072967
EGP 54.750054
ERN 16.238693
ETB 142.148138
FJD 2.528311
FKP 0.835719
GBP 0.836915
GEL 2.987844
GGP 0.835719
GHS 16.774196
GIP 0.835719
GMD 78.070637
GNF 9336.997504
GTQ 8.350907
GYD 226.474627
HKD 8.423735
HNL 27.630365
HRK 7.539136
HTG 141.398917
HUF 402.389191
IDR 17999.301766
ILS 4.003136
IMP 0.835719
INR 92.486651
IQD 1412.167485
IRR 45558.437273
ISK 142.768234
JEP 0.835719
JMD 169.469602
JOD 0.767577
JPY 161.94087
KES 139.955005
KGS 93.67456
KHR 4306.443081
KMF 492.186514
KPW 974.303226
KRW 1595.697368
KWD 0.33372
KYD 0.900296
KZT 544.95781
LAK 23309.086916
LBP 96756.949689
LKR 319.829451
LRD 215.880107
LSL 19.884615
LTL 3.196576
LVL 0.654841
LYD 5.201087
MAD 10.425105
MDL 19.462674
MGA 5027.071155
MKD 61.532014
MMK 2272.643839
MNT 3780.123823
MOP 8.673624
MRU 42.688057
MUR 49.420424
MVR 16.71429
MWK 1872.041621
MXN 22.179875
MYR 4.801467
MZN 69.162121
NAD 19.884615
NGN 1661.655597
NIO 39.710385
NOK 11.333931
NPR 148.048006
NZD 1.904726
OMR 0.416773
PAB 1.08258
PEN 3.960513
PGK 4.40689
PHP 61.979182
PKR 303.207553
PLN 4.185469
PYG 8603.81657
QAR 3.940413
RON 4.979647
RSD 117.257112
RUB 91.843055
RWF 1534.500828
SAR 4.059955
SBD 9.201828
SCR 15.498507
SDG 650.074255
SEK 10.809708
SGD 1.452674
SHP 0.850738
SLE 24.666564
SLL 22701.152509
SOS 618.302902
SRD 39.573459
STD 22407.210436
SVC 9.472435
SYP 14075.542147
SZL 19.884615
THB 36.721006
TJS 11.781454
TMT 3.787949
TND 3.365541
TOP 2.607342
TRY 41.091684
TTD 7.340106
TWD 35.957673
TZS 2867.987529
UAH 44.802126
UGX 3962.001276
USD 1.08258
UYU 45.647938
UZS 13944.514228
VES 74.920843
VND 27693.878797
VUV 133.417721
WST 3.061282
XAF 656.248686
XAG 0.031787
XAU 0.000346
XCD 2.930901
XDR 0.81666
XOF 656.248686
XPF 119.331742
YER 266.329469
ZAR 19.901928
ZMK 9744.517212
ZMW 30.485044
ZWL 348.590165
  • CMSC

    -0.0628

    22.4

    -0.28%

  • RIO

    -0.9500

    60.08

    -1.58%

  • NGG

    0.0400

    65.61

    +0.06%

  • GSK

    0.0000

    38.74

    0%

  • AZN

    -0.2900

    73.5

    -0.39%

  • BP

    -0.0700

    33.79

    -0.21%

  • RBGPF

    1.0000

    68

    +1.47%

  • BTI

    0.8600

    41.37

    +2.08%

  • RYCEF

    -0.0100

    9.69

    -0.1%

  • SCS

    -0.1400

    10.96

    -1.28%

  • CMSD

    0.1000

    22.81

    +0.44%

  • JRI

    0.0700

    12.94

    +0.54%

  • RELX

    0.2500

    50.41

    +0.5%

  • BCC

    -0.2100

    98.09

    -0.21%

  • VOD

    -0.0800

    9.37

    -0.85%

  • BCE

    -0.0100

    22.96

    -0.04%

US greenlights pig kidney transplant trials
US greenlights pig kidney transplant trials / Photo: Andrew Caballero-Reynolds - AFP/File

US greenlights pig kidney transplant trials

Two US biotech companies say the Food and Drug Administration has cleared them to conduct clinical trials of their gene-edited pig kidneys for human transplants.

Text size:

United Therapeutics along with another company, eGenesis, have been working since 2021 on experiments implanting pig kidneys into humans: initially brain-dead patients and more recently living recipients.

Advocates hope the approach will help address the severe organ shortage. More than 100,000 people in the United States are awaiting transplants, including over 90,000 in need of kidneys.

United Therapeutics's approval, announced Monday, allows the company to advance its technology toward a licensed product if the trial succeeds.

The study authorization was hailed as a "significant step forward in our relentless mission to expand the availability of transplantable organs," by Leigh Peterson, the company's executive vice president.

The trial will initially enroll six patients with end-stage renal disease before expanding to as many as 50, United Therapeutics said in a statement. The first transplant is expected in mid-2025.

Meanwhile, rival eGenesis said it had received FDA approval in December for a separate three-patient kidney study.

"The study will evaluate patients with kidney failure who are listed for a transplant but who face a low probability of receiving a deceased donor offer within a five-year timeframe," the company said.

Xenotransplantation -- transplanting organs from one species to another -- has been a tantalizing yet elusive goal for science.

Early experiments in primates faltered, but advances in gene editing and immune system management have brought the field closer to reality.

Pigs have emerged as ideal donors: they grow quickly, produce large litters, and are already part of the human food supply.

United Therapeutics said trial patients would be monitored for life, assessing survival rates, kidney function, and the risk of zoonotic infections -- diseases that jump from animals to humans.

Currently, there is only one living human recipient of a pig organ: Towana Looney, a 53-year-old from Alabama who received a United Therapeutics kidney on November 25, 2024.

She is also the longest-surviving recipient, having lived with a pig kidney for 71 days as of Tuesday. David Bennett of Maryland received a pig heart in 2022 and survived 60 days.

W.F.Portman--NZN